Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease

European Journal of Pharmacology

Volumn 657, Issue 1-3, 2011, Pages 104-110

  Han, Mei ^a   Liu, Ying ^a   Tan, Qi ^a   Zhang, Bing ^a   Wang, Wei ^a   Liu, Jian ^b   Zhang, Xiao Jun ^b   Wang, Yong Yan ^a   Zhang, Jin Ming ^b  

^a BEIJING NORMAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Alzheimer's disease; Beta amyloid; Learning and memory; Micro positron emission tomography computerized tomographic scanning; Neuroprotection; Stemazole

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; GALANTAMINE; HYDRAZINE DERIVATIVE; STEMAZOLE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG STRUCTURE; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT; TREATMENT DURATION; TREATMENT OUTCOME;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CA1 REGION, HIPPOCAMPAL; DENTATE GYRUS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDRAZINES; INJECTIONS; MEMORY DISORDERS; NEURONS; NEUROPROTECTIVE AGENTS; OXADIAZOLES; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RATS; RATS, WISTAR;

EID: 79952489024     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.01.065     Document Type: Article

References (27)

1. E. Arias, E. Ales, N.H. Gabilan, M.F. Cano-Abad, M. Villarroya, A.G. Garcia, and M.G. Lopez Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors Neuropharmacology 46 2004 103 114 (Pubitemid 37494744)
2. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, and H.M. Arrighi Forecasting the global burden of Alzheimer's disease Alzheimers Dement. 3 2007 186 191 (Pubitemid 46825511)
3. R. Cappai, and K.J. Barnham Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity Neurochem. Res. 33 2008 526 532 (Pubitemid 351230455)
4. R.J. Castellani, H.G. Lee, X.W. Zhu, G. Perry, and M.A. Smith Alzheimer disease pathology as a host response Neuropathol. Exp. Neurol. 67 2008 523 531 (Pubitemid 351787079)
5. Han, M., Feng, Y., Sun, Y.Y., 2010. Preparation of small molecule compounds for promoting stem cells hyperplasia. PCT Int. Appl. 41 pp. WO 2010130063, A1 20101118, CAN 153:643462.
6. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184 185
7. C.A. Hawkes, V. Ng, and J. McLaurin Small molecule inhibitors of A beta-aggregation and neurotoxicity Drug Dev. Res. 70 2009 111 124
8. C. Inui-Yamamoto, Y. Yoshioka, T. Inui, K.S. Sasaki, Y. Ooi, K. Ueda, A. Seiyama, and I. Ohzawa The brain mapping of the retrieval of conditioned taste aversion memory using manganese enhanced magnetic resonance imaging in rats Neuroscience 167 2010 199 204
9. R. Jakob-Roetne, and H. Jacobsen Alzheimer's disease: from pathology to therapeutic approaches Angew. Chem. Int. Ed. 48 2009 3030 3059
10. 18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease Mol. Imaging Biol. 11 2009 236 240
11. J. Lauren, D.A. Gimbel, H.B. Nygaard, J.W. Gilbert, and S.M. Strittmatter Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers Nature 457 2009 U1128 U1184
12. S. Lee, E.J. Fernandez, and T.A. Good Role of aggregation conditions in structure, stability, and toxicity of intermediates in the A beta fibril formation pathway Protein Sci. 16 2007 723 732 (Pubitemid 46507001)
13. I. Mebane-Sims, and A. Alzheimer's 2009 Alzheimer's disease facts and figures Alzheimers Dement. 5 2009 234 270
14. X.M. Meng, D.Y. Ruan, and L.D. Kang Age-related morphological impairments in the rat hippocampus following developmental lead exposure: an MRI, LM and EM study Environ. Toxicol. Pharmacol. 13 2003 187 197
15. A. Nitta, T. Fukuta, T. Hasegawa, and T. Nabeshima Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration Jpn J. Pharmacol. 73 1997 51 57 (Pubitemid 27078010)
16. J.M. Noble, and N. Scarmeas Application of PET imaging to diagnosis of Alzheimer's disease and mild cognitive impairment Int. Rev. Neurobiol. 84 2009 133 149 Neurobiology of Dementia)
17. M.Y. Noh, S.H. Koh, Y. Kim, H.Y. Kim, G.W. Cho, and S.H. Kim Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death J. Neurochem. 108 2009 1116 1125
18. M. Ogawa, Y. Iida, M. Nakagawa, Y. Kuge, H. Kawashima, A. Tominaga, M. Ueda, Y. Magata, and H. Saji Change of central cholinergic receptors following lesions of nucleus basalis magnocellularis in rats: search for an imaging index suitable for the early detection of Alzheimer's disease Nucl. Med. Biol. 33 2006 249 254
19. M.N. Sabbagh Drug development for Alzheimer's disease: where are we now and where are we headed? Am. J. Geriatr. Pharmacother. 7 2009 167 185
20. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 1991 487 498
21. J.S. Seo, T.K. Kim, Y.H. Leem, K.W. Lee, S.K. Park, I.S. Baek, K.S. Kim, G.J. Im, S.M. Lee, Y.H. Park, and P.L. Han SK-PC-B70M confers anti-oxidant activity and reduces A beta levels in the brain of Tg2576 mice Brain Res. 1261 2009 100 108
22. S. Takeda, N. Sato, K. Niisato, D. Takeuchi, H. Kurinami, M. Shinohara, H. Rakugi, M. Kano, and R. Morishita Validation of A beta 1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease Brain Res. 1280 2009 137 147
23. J. Tang, H.W. Xu, X.T. Fan, D.B. Li, D. Rancourt, G.J. Zhou, Z.F. Li, and L. Yang Embryonic stem cell-derived neural precursor cells improve memory dysfunction in A beta(1-40) injured rats Neurosci. Res. 62 2008 86 96
24. R. Wang, H.Y. Zhang, and X.C. Tang Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein (1-40) in rat Eur. J. Pharmacol. 421 2001 149 156 (Pubitemid 32539415)
25. K. Yamada, and T. Nabeshima Animal models of Alzheimer's disease and evaluation of anti-dementia drugs Pharmacol. Ther. 88 2000 93 113 (Pubitemid 32057133)
26. J.M. Zhang, Z. Guo, J.H. Tian, and W.S. Wang Synthesis and biodistribution of 2-(4′-N-11 C-methylaminophenyl)-6-hydroxy benzothiazole as a potential β-amyloid imaging agent Zhonghua Heyixue Zazhi 28 2008 397 400
27. M.Q. Zheng, D.Z. Yin, L. Zhang, B. Lei, D.F. Cheng, H.C. Cai, Y.J. Han, M.X. Wu, H. Zhang, and J. Wang Biological characters of [F-18]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging Acta Pharmacol. Sin. 29 2008 548 554 (Pubitemid 351601447)